24 May 2013
Keywords: vitravene, oked, europe, isis, pharmaceuticals, cibavision, received
Article | 05 August 1999
Isis Pharmaceuticals and CIBAVision have received approval in theEuropean Union for Vitravene (fomivirsen) for the local treatment of newly-diagnosed or ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.